CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
Human CA19-9 Antibody MAB10625-100: R&D Systems
Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter - ScienceDirect
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Changes in CA199 levels during the treatment and follow-up. The CA199... | Download Scientific Diagram
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
Sekbio CA19-9 Tumor/Cancer Marker, Cancer Antigen 19-9, CA 19-9 Blood Test China
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports